Zobrazeno 1 - 2
of 2
pro vyhledávání: '"avaliação de radiofármacos"'
Publikováno v:
Brazilian Archives of Biology and Technology, Vol 51, Iss spe, Pp 71-75 (2008)
This short review is dedicated to the current status of the assessment of a new PET radiopharmaceutical, fluoromethylcholine-(18F) or FCH, which is taken-up by prostate cancer tissue, in contrary to fluorodeoxyglucose-(18F) or FDG. It seems that FCH
Externí odkaz:
https://doaj.org/article/5ca92a3ae8334abeba083b7f2a7e67a6
Publikováno v:
Brazilian Archives of Biology and Technology, Vol 51, Iss spe, Pp 71-75 (2008)
Brazilian Archives of Biology and Technology v.51 n.spe 2008
Brazilian Archives of Biology and Technology
Instituto de Tecnologia do Paraná (Tecpar)
instacron:TECPAR
Brazilian Archives of Biology and Technology, Volume: 51, Issue: spe, Pages: 71-75, Published: DEC 2008
Brazilian Archives of Biology and Technology v.51 n.spe 2008
Brazilian Archives of Biology and Technology
Instituto de Tecnologia do Paraná (Tecpar)
instacron:TECPAR
Brazilian Archives of Biology and Technology, Volume: 51, Issue: spe, Pages: 71-75, Published: DEC 2008
This short review is dedicated to the current status of the assessment of a new PET radiopharmaceutical, fluoromethylcholine-(18F) or FCH, which is taken-up by prostate cancer tissue, in contrary to fluorodeoxyglucose-(18F) or FDG. It seems that FCH